US Stock MarketDetailed Quotes

ZBIO Zenas BioPharma

Watchlist
  • 10.010
  • +0.250+2.56%
Close Dec 20 16:00 ET
  • 10.030
  • +0.020+0.20%
Post 17:17 ET
418.33MMarket Cap-3.24P/E (TTM)

Zenas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.1M
53.50%-30.53M
10.08%-15.4M
31.85M
-20.91M
-26.06M
-65.65M
-17.13M
Net income from continuing operations
-208.43%-38.61M
-30.74%-37.98M
-45.57%-27.8M
68.88%-37.12M
-29.45%-24.59M
--35.61M
---29.05M
---19.1M
---119.28M
---18.99M
Operating gains losses
----
----
----
----
----
----
----
----
--13.27M
--0
Depreciation and amortization
38.46%36K
20.69%35K
17.86%33K
44.87%113K
20.00%30K
--26K
--29K
--28K
--78K
--25K
Other non cash items
-27.75%125K
-97.15%291K
346.60%853K
-65.09%11.03M
47.25%455K
--173K
--10.21M
--191K
--31.58M
--309K
Change In working capital
191.54%4.54M
286.14%5.16M
187.21%6.87M
-200.90%-8.04M
508.28%7.57M
---4.96M
---2.77M
---7.87M
--7.97M
--1.24M
-Change in prepaid assets
159.33%1.79M
-286.78%-3.1M
299.66%1.79M
24.93%-3.35M
100.74%1.37M
---3.02M
---802K
---895K
---4.46M
--680K
-Change in payables and accrued expense
292.11%3.41M
623.70%9.37M
155.31%3.74M
-130.25%-3.98M
654.51%6.35M
---1.77M
---1.79M
---6.77M
--13.15M
--842K
-Change in other current liabilities
-278.03%-654K
-520.67%-1.11M
733.18%1.34M
0.42%-714K
45.68%-151K
---173K
---179K
---211K
---717K
---278K
Cash from discontinued investing activities
Operating cash flow
-197.53%-31.06M
-48.04%-30.96M
26.71%-19.1M
53.50%-30.53M
10.08%-15.4M
--31.85M
---20.91M
---26.06M
---65.65M
---17.13M
Investing cash flow
Cash flow from continuing investing activities
-26.76M
-35K
-22K
99.23%-17K
98.42%-17K
0
0
0
-2.2M
-1.07M
Net PPE purchase and sale
--0
---35K
---22K
91.41%-17K
77.03%-17K
--0
--0
--0
---198K
---74K
Net intangibles purchase and sale
----
----
----
--0
----
----
----
----
---2M
---1M
Cash from discontinued investing activities
Investing cash flow
---26.76M
---35K
---22K
99.23%-17K
98.42%-17K
--0
--0
--0
---2.2M
---1.07M
Financing cash flow
Cash flow from continuing financing activities
1,069.90%233.98M
1,615,709.09%177.74M
-1,216.36%-614K
-66.13%20.12M
-99.92%50K
20M
11K
55K
59.39M
59.39M
Net issuance payments of debt
----
----
----
--20M
--0
----
----
----
--0
--0
Net preferred stock issuance
--0
----
----
--0
--0
--0
----
----
--59.39M
----
Proceeds from stock option exercised by employees
--32K
1,027.27%124K
-23.64%42K
--116K
--50K
--0
--11K
--55K
--0
--0
Net other financing activities
---439K
---766K
---656K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,069.90%233.98M
1,615,709.09%177.74M
-1,216.36%-614K
-66.13%20.12M
-99.92%50K
--20M
--11K
--55K
--59.39M
--59.39M
Net cash flow
Beginning cash position
795.60%184.02M
-9.79%37.24M
-15.38%56.94M
-11.21%67.3M
177.52%72.4M
--20.55M
--41.28M
--67.3M
--75.8M
--26.09M
Current changes in cash
239.78%176.16M
802.10%146.75M
24.11%-19.74M
-23.30%-10.43M
-137.31%-15.37M
--51.85M
---20.9M
---26.01M
---8.46M
--41.19M
Effect of exchange rate changes
-1,400.00%-52K
-80.72%32K
820.00%36K
290.24%78K
-583.33%-87K
--4K
--166K
---5K
---41K
--18K
End cash Position
397.43%360.13M
795.60%184.02M
-9.79%37.24M
-15.38%56.94M
-15.38%56.94M
--72.4M
--20.55M
--41.28M
--67.3M
--67.3M
Free cash flow
-197.53%-31.06M
-48.21%-30.99M
26.62%-19.12M
54.98%-30.55M
15.30%-15.42M
--31.85M
---20.91M
---26.06M
---67.85M
---18.2M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -197.53%-31.06M-48.04%-30.96M26.71%-19.1M53.50%-30.53M10.08%-15.4M31.85M-20.91M-26.06M-65.65M-17.13M
Net income from continuing operations -208.43%-38.61M-30.74%-37.98M-45.57%-27.8M68.88%-37.12M-29.45%-24.59M--35.61M---29.05M---19.1M---119.28M---18.99M
Operating gains losses ----------------------------------13.27M--0
Depreciation and amortization 38.46%36K20.69%35K17.86%33K44.87%113K20.00%30K--26K--29K--28K--78K--25K
Other non cash items -27.75%125K-97.15%291K346.60%853K-65.09%11.03M47.25%455K--173K--10.21M--191K--31.58M--309K
Change In working capital 191.54%4.54M286.14%5.16M187.21%6.87M-200.90%-8.04M508.28%7.57M---4.96M---2.77M---7.87M--7.97M--1.24M
-Change in prepaid assets 159.33%1.79M-286.78%-3.1M299.66%1.79M24.93%-3.35M100.74%1.37M---3.02M---802K---895K---4.46M--680K
-Change in payables and accrued expense 292.11%3.41M623.70%9.37M155.31%3.74M-130.25%-3.98M654.51%6.35M---1.77M---1.79M---6.77M--13.15M--842K
-Change in other current liabilities -278.03%-654K-520.67%-1.11M733.18%1.34M0.42%-714K45.68%-151K---173K---179K---211K---717K---278K
Cash from discontinued investing activities
Operating cash flow -197.53%-31.06M-48.04%-30.96M26.71%-19.1M53.50%-30.53M10.08%-15.4M--31.85M---20.91M---26.06M---65.65M---17.13M
Investing cash flow
Cash flow from continuing investing activities -26.76M-35K-22K99.23%-17K98.42%-17K000-2.2M-1.07M
Net PPE purchase and sale --0---35K---22K91.41%-17K77.03%-17K--0--0--0---198K---74K
Net intangibles purchase and sale --------------0-------------------2M---1M
Cash from discontinued investing activities
Investing cash flow ---26.76M---35K---22K99.23%-17K98.42%-17K--0--0--0---2.2M---1.07M
Financing cash flow
Cash flow from continuing financing activities 1,069.90%233.98M1,615,709.09%177.74M-1,216.36%-614K-66.13%20.12M-99.92%50K20M11K55K59.39M59.39M
Net issuance payments of debt --------------20M--0--------------0--0
Net preferred stock issuance --0----------0--0--0----------59.39M----
Proceeds from stock option exercised by employees --32K1,027.27%124K-23.64%42K--116K--50K--0--11K--55K--0--0
Net other financing activities ---439K---766K---656K----------------------------
Cash from discontinued financing activities
Financing cash flow 1,069.90%233.98M1,615,709.09%177.74M-1,216.36%-614K-66.13%20.12M-99.92%50K--20M--11K--55K--59.39M--59.39M
Net cash flow
Beginning cash position 795.60%184.02M-9.79%37.24M-15.38%56.94M-11.21%67.3M177.52%72.4M--20.55M--41.28M--67.3M--75.8M--26.09M
Current changes in cash 239.78%176.16M802.10%146.75M24.11%-19.74M-23.30%-10.43M-137.31%-15.37M--51.85M---20.9M---26.01M---8.46M--41.19M
Effect of exchange rate changes -1,400.00%-52K-80.72%32K820.00%36K290.24%78K-583.33%-87K--4K--166K---5K---41K--18K
End cash Position 397.43%360.13M795.60%184.02M-9.79%37.24M-15.38%56.94M-15.38%56.94M--72.4M--20.55M--41.28M--67.3M--67.3M
Free cash flow -197.53%-31.06M-48.21%-30.99M26.62%-19.12M54.98%-30.55M15.30%-15.42M--31.85M---20.91M---26.06M---67.85M---18.2M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
NVIDIA
NVDA
+3.08%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Alphabet-C
GOOG
+1.72%

Unlock the Full List

Investment Theme Recent IPOs
Recent IPOs
Intraday+0.71%